Related Experiment Video
Updated: Jan 14, 2026

In Vivo Imaging of Reactive Oxygen Species in a Murine Wound Model
Published on: November 17, 2018
Gold-Decorated Upconversion Luminescent Nanozyme Enables ROS-Responsive Antioxidant for Myocardial Injury Repair
1Xiamen Cardiovascular Hospital of Xiamen University, School of Medicine, Fujian Branch of National Clinical Research Center for Cardiovascular Diseases, Xiamen, China, No. 2999 Jinshan Road, Huli District, Xiamen, Fujian 361004, P.R. China.
None:
Nanozyme materials open up new opportunities in reactive oxygen species (ROS)-related heart diseases. However, the development of a stable and efficacious nanozyme for treating cardiac injuries remains a significant challenge. Herein, we report a novel mechanistic design to realize efficient ROS catalysis in Yb/Er/CeOF@SiO2@Au upconversion nanoparticles (UCNPs), which protects heart cells from oxidative injury via scavenging cellular ROS. The incorporation of Yb3+ and Er3+ ions acts as a catalytic enhancer, endowing the UCNPs with versatile multienzyme mimicry capabilities, such as those of superoxide dismutase and glutathione peroxidase. Moreover, the Yb/Er/CeOF@SiO2@Au nanoparticles exhibit efficient red upconversion emission and high-temperature sensitivities, resulting in excellent fluorescence localization and temperature stability. H2O2 and LPS-induced myocardial damage can be effectively treated with the injection of UCNPs. Yb/Er/CeOF@SiO2@Au improves mitochondrial function and oxidative phosphorylation, which decreases myocardial cell damage and biotoxicity both in vitro and in vivo. Therefore, Yb/Er/CeOF@SiO2@Au represents a novel nanozyme with significant potential in cardiovascular disease therapeutics.

